As of 2026-03-14, the Relative Valuation of Ondine Biomedical Inc (OBI.L) is - GBP. This relative valuation is based on P/E multiples. With the latest stock price at 11.00 GBP, the upside of Ondine Biomedical Inc based on Relative Valuation is -.
The range of the Relative Valuation is - GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-03-12 | -4.35 |
| 2026-03-11 | -4.35 |
| 2026-03-10 | -4.35 |
| 2026-03-09 | -4.06 |
| 2026-03-06 | -4.07 |
| 2026-03-05 | -4.05 |
| 2026-03-04 | -4.05 |
| 2026-03-03 | -4.06 |
| 2026-03-02 | -4.06 |
| 2026-02-27 | -4.07 |
| 2026-02-26 | -4.05 |
| 2026-02-25 | -4.05 |
| 2026-02-24 | -3.96 |
| 2026-02-23 | -3.86 |
| 2026-02-20 | -3.88 |
| 2026-02-19 | -3.75 |
| 2026-02-18 | -3.76 |
| 2026-02-17 | -3.66 |
| 2026-02-16 | -3.67 |
| 2026-02-13 | -3.68 |
| 2026-02-12 | -3.65 |
| 2026-02-11 | -3.66 |
| 2026-02-10 | -3.66 |
| 2026-02-09 | -3.57 |
| 2026-02-06 | -3.58 |
| 2026-02-05 | -3.56 |
| 2026-02-04 | -3.36 |
| 2026-02-03 | -3.37 |
| 2026-02-02 | -3.37 |
| 2026-01-30 | -3.38 |
| 2026-01-29 | -3.36 |
| 2026-01-28 | -3.36 |
| 2026-01-27 | -3.37 |
| 2026-01-26 | -3.37 |
| 2026-01-23 | -3.38 |
| 2026-01-22 | -3.26 |
| 2026-01-21 | -3.17 |
| 2026-01-20 | -3.17 |
| 2026-01-19 | -3.17 |
| 2026-01-16 | -3.18 |
| 2026-01-15 | -3.16 |
| 2026-01-14 | -3.17 |
| 2026-01-13 | -3.17 |
| 2026-01-12 | -3.17 |
| 2026-01-09 | -3.20 |
| 2026-01-08 | -3.26 |
| 2026-01-07 | -3.22 |
| 2026-01-06 | -3.47 |
| 2026-01-05 | -3.47 |
| 2026-01-02 | -3.48 |